A carregar...

Mid-stage intervention achieves similar efficacy as conventional early-stage treatment using gene therapy in a pre-clinical model of retinitis pigmentosa

Deficiencies in rod-specific cyclic guanosine monophosphate (cGMP) phosphodiesterase-6 (PDE6) are the third most common cause of autosomal recessive retinitis pigmentosa (RP). Previously, viral gene therapy approaches on pre-clinical models with mutations in PDE6 have demonstrated that the photorece...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wert, Katherine J., Sancho-Pelluz, Javier, Tsang, Stephen H.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3869365/
https://ncbi.nlm.nih.gov/pubmed/24101599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddt452
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!